In recent trading, the ASX200 experienced a slight decline, influenced by shifts in consumer discretionary stocks and banking shares, as well as comments from RBA Governor Michele Bullock regarding interest rate adjustments. Amidst this backdrop of market fluctuations and sector-specific performances, dividend stocks remain an attractive option for investors seeking stable returns; they can provide a buffer against volatility while offering consistent income streams. Top 10 Dividend Stocks In Australia Name Dividend Yield Dividend Rating IPH (ASX:IPH) 7.08% ★★★★★☆ Super Retail Group (ASX:SUL) 8.40% ★★★★★☆ Lycopodium (ASX:LYL) 7.48% ★★★★★☆ Fiducian Group (ASX:FID) 4.07% ★★★★★☆ Nick Scali (ASX:NCK) 3.50% ★★★★★☆ MFF Capital Investments (ASX:MFF) 3.41% ★★★★★☆ Premier Investments (ASX:PMV) 5.99% ★★★★★☆ National Storage REIT (ASX:NSR) 4.89% ★★★★★☆ Sugar Terminals (NSX:SUG) 7.74% ★★★★☆☆ Ricegrowers (ASX:SGLLV) 5.17% ★★★★☆☆ Click here to see the full list of 30 stocks from our Top ASX Dividend Stocks screener. Here's a peek at a few of the choices from the screener. GWA Group Simply Wall St Dividend Rating: ★★★★☆☆ Overview: GWA Group Limited is engaged in the research, design, manufacture, import, and marketing of building fixtures and fittings for residential and commercial properties across Australia, New Zealand, and international markets with a market cap of A$663.01 million. Operations: GWA Group Limited generates revenue from its Water Solutions segment, which contributed A$417.40 million. Dividend Yield: 6.4% GWA Group's recent dividend increase to A$0.075 per share, payable March 7, 2025, underscores its commitment to shareholders despite a high payout ratio of 111.7%, indicating dividends are not well-covered by earnings. However, the cash payout ratio of 74.3% suggests dividends are supported by cash flows. The company's dividend yield is among the top quartile in Australia but has been historically volatile and unreliable over the past decade, highlighting potential risks for investors prioritizing stability. Unlock comprehensive insights into our analysis of GWA Group stock in this dividend report. Our valuation report unveils the possibility GWA Group's shares may be trading at a discount.ASX:GWA Dividend History as at Feb 2025 IPH Simply Wall St Dividend Rating: ★★★★★☆ Overview: IPH Limited, along with its subsidiaries, offers intellectual property services and products and has a market capitalization of A$1.35 billion. Operations: IPH Limited generates revenue through its intellectual property services and products. Dividend Yield: 7.1% IPH Limited's recent earnings report shows a strong performance with increased sales and revenue, yet its dividend yield of 7.09% is not well-supported by earnings given the high payout ratio of 116.2%. However, dividends are covered by cash flows at an 86.9% cash payout ratio, indicating some level of sustainability. IPH's dividends have been stable and growing over the past decade, offering reliability despite coverage concerns. The stock trades at a favorable value compared to peers. Story Continues Dive into the specifics of IPH here with our thorough dividend report. Upon reviewing our latest valuation report, IPH's share price might be too pessimistic.ASX:IPH Dividend History as at Feb 2025 Medibank Private Simply Wall St Dividend Rating: ★★★★☆☆ Overview: Medibank Private Limited operates as a provider of private health insurance and health services in Australia, with a market cap of A$10.88 billion. Operations: Medibank Private Limited generates revenue primarily from its Health Insurance segment, which accounts for A$7.90 billion, and its Medibank Health segment, contributing A$360.10 million. Dividend Yield: 4.2% Medibank Private's dividend yield of 4.2% is lower than the top quartile in Australia, and its high payout ratio of 92.8% indicates dividends aren't well-covered by earnings. However, with a cash payout ratio of 56.4%, dividends are supported by cash flows, providing some stability. Over the past decade, Medibank has consistently increased its dividends with minimal volatility, though future sustainability may be challenged without improved earnings coverage. Click here and access our complete dividend analysis report to understand the dynamics of Medibank Private. Our comprehensive valuation report raises the possibility that Medibank Private is priced lower than what may be justified by its financials.ASX:MPL Dividend History as at Feb 2025 Next Steps Delve into our full catalog of 30 Top ASX Dividend Stocks here. Have you diversified into these companies? Leverage the power of Simply Wall St's portfolio to keep a close eye on market movements affecting your investments. Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor. Looking For Alternative Opportunities? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:GWA ASX:IPH and ASX:MPL. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected] View Comments
3 ASX Dividend Stocks To Enhance Your Portfolio
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...